Melissa Malhame
Vice President, Business Development
Melissa joined in December 2020 as the Vice President of Business Development. She brings more than two decades of global vaccine experience spanning the private and public sectors. Melissa has supported the World Health Organization, the Wellcome Trust, the Coalitions for Epidemic Preparedness Innovation, and the Bill and Melinda Gates Foundation as a consultant. Between 2013 and 2018, she led market shaping efforts for Gavi, The Vaccine Alliance where she was accountable for ensuring supply of vaccines at affordable prices, for setting long-term access strategies and for leading Alliance relationships with the vaccine industry. Previously Ms. Malhame led and contributed to business development, strategic planning and late-stage program leadership focused on a now-licensed novel hepatitis B vaccine at Dynavax Technologies. Melissa joined Dynavax following a decade in progressively senior vaccine marketing and sales roles with Merck. Melissa serves in advisory roles to the RIGHT Fund, the Biotechnology Innovation Organization, PharmaJet Inc. and MedAccess. Melissa has an MBA from Cornell University and BA in International Affairs and Economics from Lafayette College.